A.H. Jan Danser

28.2k total citations · 5 hit papers
465 papers, 18.8k citations indexed

About

A.H. Jan Danser is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, A.H. Jan Danser has authored 465 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 258 papers in Cardiology and Cardiovascular Medicine, 183 papers in Endocrinology, Diabetes and Metabolism and 151 papers in Molecular Biology. Recurrent topics in A.H. Jan Danser's work include Renin-Angiotensin System Studies (188 papers), Hormonal Regulation and Hypertension (157 papers) and Receptor Mechanisms and Signaling (91 papers). A.H. Jan Danser is often cited by papers focused on Renin-Angiotensin System Studies (188 papers), Hormonal Regulation and Hypertension (157 papers) and Receptor Mechanisms and Signaling (91 papers). A.H. Jan Danser collaborates with scholars based in Netherlands, United States and Germany. A.H. Jan Danser's co-authors include Maarten A.D.H. Schalekamp, Anton H. van den Meiracker, Ingrid M. Garrelds, F. H. M. Derkx, Pramod R. Saxena, Joep H.M. van Esch, Wendy W. Batenburg, Heribert Schunkert, Anton J.M. Roks and Jaap Deinum and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

A.H. Jan Danser

445 papers receiving 18.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-Converting Enzyme in the Human Heart

1995 627 citations A.H. Jan Danser, Antoinette MaassenVanDenBrink et al. profile →
Hypertension

2015 529 citations Anton J.M. Roks, A.H. Jan Danser et al. profile →
Renin-Angiotensin System Blockers and the COVID-19 Pandemic

2020 354 citations A.H. Jan Danser et al. Hypertension profile →
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

2019 253 citations Marcel H.A. Muskiet, Lennart Tonneijck et al. profile →
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure

2019 248 citations A.H. Jan Danser, Marko Poglitsch et al. profile →

Peers

Countries citing papers authored by A.H. Jan Danser

Since Specialization

Citations

This map shows the geographic impact of A.H. Jan Danser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.H. Jan Danser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.H. Jan Danser more than expected).

Fields of papers citing papers by A.H. Jan Danser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.H. Jan Danser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.H. Jan Danser. The network helps show where A.H. Jan Danser may publish in the future.

Co-authorship network of co-authors of A.H. Jan Danser

This figure shows the co-authorship network connecting the top 25 collaborators of A.H. Jan Danser. A scholar is included among the top collaborators of A.H. Jan Danser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.H. Jan Danser. A.H. Jan Danser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders 2025 ·British Journal of Pharmacology ·(unknown), (unknown), Dennis J.L.G. Schutter, Antoon van den Bogaerdt, Arnaud J.P.E. Vincent, Carlos M. Villalón, A.H. Jan Danser, Antoinette MaassenVanDenBrink	2
2	Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management? 2025 ·Hypertension ·(unknown), Dominik Kylies, A.H. Jan Danser, Ulrich Wenzel	1
3	Combination therapy in preclinical studies and clinical trials: Evidence, gaps and the path ahead 2025 ·British Journal of Pharmacology ·Shanshan Li, (unknown), A.H. Jan Danser, Ulrich Wenzel	0
4	Innovative hypertension treatments: Transitioning from conventional therapies to siRNA-based solutions 2024 ·European Journal of Pharmacology ·(unknown), Joseph Pierre Aboumsallem, Wouter C. Meijers, Rudolf A. de Boer, A.H. Jan Danser	1
5	Vacuolar H⁺‐ATPase in Diabetes, Hypertension, and Atherosclerosis 2024 ·Microcirculation ·Na Wang, Liwei Ren, A.H. Jan Danser	7
6	First-trimester maternal tryptophan metabolites, utero-placental (vascular)development and hypertensive disorders of pregnancy: The Rotterdam periconceptional cohort 2024 ·Placenta ·(unknown), Michelle Broekhuizen, Mina Mirzaian, Lenie van Rossem, A.H. Jan Danser, Sten P. Willemsen, (unknown), Anton H. J. Koning, A. Mulders, Ron H. N. van Schaik, Régine P.M. Steegers‐Theunissen	2
7	Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia 2024 ·Hypertension ·Lunbo Tan, (unknown), (unknown), Michelle Broekhuizen, Zhongli Chen, (unknown), Sam Schoenmakers, Elisabeth J. Ruijgrok, (unknown), Brenda C. M. de Winter, Antoon J. van den Bogaerdt, Xifeng Lu, A.H. Jan Danser, Koen Verdonk	14
8	Statins, but not PCSK9 inhibitors, reduce the adipokine chemerin in familial hypercholesterolemia: Focus on lipoprotein subfractions 2023 ·Atherosclerosis ·Lunbo Tan, Na Wang, (unknown), Jeanine E. Roeters van Lennep, Monique T. Mulder, Xifeng Lu, A.H. Jan Danser, Koen Verdonk	1
9	Clinical Impact and Mechanisms of Nonatherosclerotic Vascular Aging: The New Kid to Be Blocked 2023 ·Canadian Journal of Cardiology ·(unknown), (unknown), (unknown), Daniël Bos, Bruno H. Stricker, A.H. Jan Danser, Francesco Mattace‐Raso, Anton J.M. Roks	2
10	Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen 2022 ·Journal of the American Heart Association ·Estrellita Uijl, Dien Ye, Liwei Ren, Katrina M. Mirabito Colafella, Richard van Veghel, Ingrid M. Garrelds, Hong Lü, Alan Daugherty, Ewout J. Hoorn, Paul Nioi, Don Foster, A.H. Jan Danser	25
11	Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects 2022 ·British Journal of Pharmacology ·Michelle Broekhuizen, René de Vries, (unknown), Willem A. Dik, Sam Schoenmakers, Birgit C. P. Koch, Daphne Merkus, Irwin Reiss, A.H. Jan Danser, Sinno H. P. Simons, (unknown)	8
12	Contraction pressure analysis using optical imaging in normal and MYBPC3-mutated hiPSC-derived cardiomyocytes grown on matrices with tunable stiffness 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Óscar Bártulos, (unknown), Stefan Braam, (unknown), A.H. Jan Danser, Daniëlle Majoor‐Krakauer, Erik Meijering, Ingrid van der Pluijm, Jeroen Essers	2
13	The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target? 2021 ·International Journal of Environmental Research and Public Health ·Michelle Broekhuizen, A.H. Jan Danser, Irwin Reiss, Daphne Merkus	33
14	Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors 2021 ·Basic Research in Cardiology ·Jens van de Wouw, Oana Sorop, (unknown), Jaap A. Joles, A.H. Jan Danser, Marianne C. Verhaar, Daphne Merkus, Dirk J. Duncker	16
15	Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes ( RENALIS ): A predefined substudy of a randomized, double‐blind trial 2021 ·Diabetes Obesity and Metabolism ·Marcel H.A. Muskiet, Lennart Tonneijck, Mark M. Smits, Mark H.H. Kramer, D. Margriet Ouwens, Bolette Hartmann, Jens J. Holst, A.H. Jan Danser, Jaap A. Joles, Daniël H. van Raalte	6
16	l -Tryptophan–Induced Vasodilation Is Enhanced in Preeclampsia 2020 ·Hypertension ·Michelle Broekhuizen, Théo Klein, (unknown), Yolanda B. de Rijke, Sam Schoenmakers, Peter Sedlmayr, A.H. Jan Danser, Daphne Merkus, Irwin Reiss	36
17	Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen 2019 ·Hypertension ·Estrellita Uijl, Katrina M. Mirabito Colafella, Yuan Sun, Liwei Ren, Richard van Veghel, Ingrid M. Garrelds, René de Vries, Marko Poglitsch, Ivan Zlatev, Jae Bum Kim, Ewout J. Hoorn, Don Foster, A.H. Jan Danser	88
18	Transition from post‐capillary pulmonary hypertension to combined pre‐ and post‐capillary pulmonary hypertension in swine: a key role for endothelin 2018 ·The Journal of Physiology ·Richard W. B. van Duin, Kelly Stam, (unknown), André Uitterdijk, Ana García‐Álvarez, Borja Ibáñez, A.H. Jan Danser, Irwin Reiss, Dirk J. Duncker, Daphne Merkus	24
19	Sex differences in pulmonary vascular control: focus on the nitric oxide pathway 2017 ·Physiological Reports ·(unknown), A.H. Jan Danser, Irwin Reiss, Dirk J. Duncker, Daphne Merkus	4
20	Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II 2006 ·Hypertension ·Jasper J. Saris, Peter A.C. ’t Hoen, Ingrid M. Garrelds, Dick H. W. Dekkers, Johan T. den Dunnen, Jos M. J. Lamers, A.H. Jan Danser	196

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact